Indian Journal of Drugs and Diseases

Open Access Open Access  Restricted Access Subscription Access

A Lethal Switch "the Dengue - an Inclusive Review"


Affiliations
1 Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu
2 Kamalaktchi Pandurangan College of Pharmacy, Thiruvannamalai, Tamilnadu, India
3 Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu, India
 

Dengue fever also known as break bone fever, is a self limited, systematic viral infection transmitted between humans by mosquitoes. It leads to a public health challenge with an economic saddle. Its symptoms include fever, headache, muscle and joint pains, and a characteristic skin rash that is similar to measles. In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs. Dengue fever is a serious threat to global health issues. Approximately 100 countries are endemic for dengue fever and 40% of the world's population or about 2.5 billion people in the tropical and sub-tropics have an increased risk of catching the disease. So, to the core of the review we are ought to discuss about a wide topics towards the symptoms, Mechanism of the virus in the host, penetration towards our body, Characteristic antibody responses, life cycle, various phases involved in the cycle, efficient vector control strategies, pathogenesis, Diagnosis, ongoing therapies, and its management and prevention. In addition, we ought to suggest at conclusion that would be a better way to research in this type of disease with reviews.

Keywords

Break Bone Fever, Dengue Hemorrhagic Fever, Dengue Shock Syndrome, Flavivirus Vectors
User
Notifications

  • Ackermann M and Padmanabhan R (2001) De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase. J. Biol. Chem. 276 (43), 39926–39937.

  • Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J and Schols D (2009) Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Virology. 387, 67-75.

  • Ananda Rao R, Swaminathan S, Fernando S, Jana AM and Khanna N (2005) A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent. Protein Exp. Purif. 41, 136-147.

  • Atrasheuskaya A, Petzelbauer P, Fredeking TM and Ignatyev G (2003) Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol. Med. Microbiol. 35 (1), 33-42.

  • Blaney Jr JE, Sathe NS, Goddard L, Hanson CT, Romero TA, Hanley KA, et al(2008) Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4. Vaccine. 26(6), 817-828.

  • Bruno Guy et al (2010) Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses evaluation of Chimeri Vax-based vaccines, Vaccine 28, 632 – 649.

  • Cangel PY, Chan et al (2006) Detection of serum neopterin for early assessment of dengue virus infection. J. Infection, 53, 152, e158. dengue virus envelope protein to human myelomonocytic cells and B lymphocytes. Virus Res. 57, 63-79.

  • Fried JR, Gibbons RV, Kalayanarooj S et al. (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl. Trop. Dis. 4, e617.

  • Helle Bielefeldt-Ohmann (1998) Analysis of antibody-independent binding of dengue viruses and

  • Huan-Yao Lei et al (2001) Immunopathogenesis of Dengue Virus Infection. J. Biomed. Sci. 8,377-388.

  • Melino S and Paci M (2007) Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach. FEBS J. 274, 2986–3002.

  • Michelle Meyer et al (2000) Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains. Virus Res. 73, 81-89.

  • Mishra KP et al (2012) Dengue virus infection induces upregulation of hn RNP-H and PDIA3 for its multiplication in the host cell. Virus Res. 163, 573-579.

  • Osmali Osmana et al (2008) Complete genome sequence analysis of dengue virus type 2 isolated in Brunei. Virus Res. 135 (2008) 48–52.

  • Ratree Takhampunya et al (2009) Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon. signalling ability. Virus Res. 145, 31-38.

  • Ravulapalli AnandaRao et al (2005) The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides. Virus Res. 112, 60-68.

  • Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, Boshell J, de Mesa MT, Nogueira RM and da Rosa AT (1997) Origins of dengue type 2 Viruses associated with increased pathogenicity in the Americas. Virology. 230(2), 244-251.

  • Rossi SL et al (2012) Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains. Virology .423, 58-67.

  • Sabin AB (1952) Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1(1), 30-50.

  • Salvador Chavez-Salinas et al (2008) Heat shock effect upon dengue virus replication into U937 cells. Virus Res. 138, 111-118.


Abstract Views: 534

PDF Views: 460




  • A Lethal Switch "the Dengue - an Inclusive Review"

Abstract Views: 534  |  PDF Views: 460

Authors

R. Uthaya
Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu
Vaikumdam Kannabirran
Kamalaktchi Pandurangan College of Pharmacy, Thiruvannamalai, Tamilnadu, India
Senguttuvan Sivan Mozhi
Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu, India
P. Vidhya Priya
Prist University, Department of Biotechnology, Puducherry Campus, Puducherry. Surya School of Pharmacy, Vikravandi, Villupuram, Tamilnadu, India

Abstract


Dengue fever also known as break bone fever, is a self limited, systematic viral infection transmitted between humans by mosquitoes. It leads to a public health challenge with an economic saddle. Its symptoms include fever, headache, muscle and joint pains, and a characteristic skin rash that is similar to measles. In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs. Dengue fever is a serious threat to global health issues. Approximately 100 countries are endemic for dengue fever and 40% of the world's population or about 2.5 billion people in the tropical and sub-tropics have an increased risk of catching the disease. So, to the core of the review we are ought to discuss about a wide topics towards the symptoms, Mechanism of the virus in the host, penetration towards our body, Characteristic antibody responses, life cycle, various phases involved in the cycle, efficient vector control strategies, pathogenesis, Diagnosis, ongoing therapies, and its management and prevention. In addition, we ought to suggest at conclusion that would be a better way to research in this type of disease with reviews.

Keywords


Break Bone Fever, Dengue Hemorrhagic Fever, Dengue Shock Syndrome, Flavivirus Vectors

References